Characterization of Pgp3, a Chlamydia Trachomatis Plasmid-encoded Immunodominant Antigen

Overview

Journal J Bacteriol

Publisher American Society for Microbiology

Specialty Microbiology

Date 2010 Sep 21

PMID 20851898

Citations 54

Authors

Ding Chen

Lei Lei

Chunxue Lu

Ahmad Galaleldeen

P John Hart

Guangming Zhong

Affiliations

Soon will be listed here.

Abstract

Human antibody recognition of Chlamydia trachomatis plasmid-encoded Pgp3 protein is dependent on the native conformation of Pgp3. The structural basis for the conformation dependence and the function of Pgp3 remain unknown. Here, we report that Pgp3 trimerization is required for the recognition of Pgp3 by human antibodies. In a native polyacrylamide gel, Pgp3 purified from a bacterial expression system migrated as stable trimers that were dissociated into monomers only by treatment with urea or sodium dodecyl sulfate (SDS) but not nonionic detergents. Human antibodies recognized trimeric but not monomeric Pgp3, suggesting that Pgp3 is presented to the human immune system as trimers during C. trachomatis infection. The endogenous Pgp3 secreted into the chlamydial outer membrane complex or host cell cytosol is always trimerized. Intact Pgp3 trimers were eluted from the outer membrane complex by a combination of nonionic detergents with reducing agents but not by the presence of either alone. These observations have provided important information for further understanding the role of Pgp3 in chlamydial pathogenesis and potentially optimizing Pgp3 as a subunit vaccine candidate antigen.

Citing Articles

Regulation of chlamydial spreading from the small intestine to the large intestine by IL-22-producing CD4 T cells.

Xu Y, Wang Y, Winner H, Yang H, He R, Wang J Infect Immun. 2023; 92(1):e0042123.

PMID: 38047677 PMC: 10790816. DOI: 10.1128/iai.00421-23.

Preclinical screen for protection efficacy of chlamydial antigens that are immunogenic in humans.

Lu C, Wang J, Zhong G Infect Immun. 2023; 91(11):e0034923.

PMID: 37889004 PMC: 10652899. DOI: 10.1128/iai.00349-23.

Plasmid-mediated virulence in .

Turman B, Darville T, OConnell C Front Cell Infect Microbiol. 2023; 13:1251135.

PMID: 37662000 PMC: 10469868. DOI: 10.3389/fcimb.2023.1251135.

A Machine Learning-Based Analytic Pipeline Applied to Clinical and Serum IgG Immunoproteome Data To Predict Chlamydia trachomatis Genital Tract Ascension and Incident Infection in Women.

Liu C, Mokashi N, Darville T, Sun X, OConnell C, Hufnagel K Microbiol Spectr. 2023; 11(4):e0468922.

PMID: 37318345 PMC: 10434056. DOI: 10.1128/spectrum.04689-22.

Protective Immunity against Lung Infection Induced by a DNA Plasmid Vaccine Carrying Gene Inhibits Dissemination in BALB/c Mice.

Wang C, Jin Y, Wang J, Zheng K, Lei A, Lu C Int J Mol Sci. 2023; 24(8).

PMID: 37108176 PMC: 10138700. DOI: 10.3390/ijms24087013.

References

Wang J, Zhang Y, Lu C, Lei L, Yu P, Zhong G . A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans. J Immunol. 2010; 185(3):1670-80. DOI: 10.4049/jimmunol.1001240. View

Carlson J, Whitmire W, Crane D, Wicke L, Virtaneva K, Sturdevant D . The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor. Infect Immun. 2008; 76(6):2273-83. PMC: 2423098. DOI: 10.1128/IAI.00102-08. View

Li Z, Wang S, Wu Y, Zhong G, Chen D . Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice. Sci China C Life Sci. 2008; 51(11):973-80. DOI: 10.1007/s11427-008-0130-9. View

Engel J . Tarp and Arp: How Chlamydia induces its own entry. Proc Natl Acad Sci U S A. 2004; 101(27):9947-8. PMC: 454194. DOI: 10.1073/pnas.0403633101. View

Donati M, Sambri V, Comanducci M, Di Leo K, Storni E, Giacani L . DNA immunization with pgp3 gene of Chlamydia trachomatis inhibits the spread of chlamydial infection from the lower to the upper genital tract in C3H/HeN mice. Vaccine. 2003; 21(11-12):1089-93. DOI: 10.1016/s0264-410x(02)00631-x. View

Da Ros C, da Silva Schmitt C . Global epidemiology of sexually transmitted diseases. Asian J Androl. 2007; 10(1):110-4. DOI: 10.1111/j.1745-7262.2008.00367.x. View

Simms I, Ward H, Martin I, Alexander S, Ison C . Lymphogranuloma venereum in Australia. Sex Health. 2006; 3(3):131-3. DOI: 10.1071/sh06039. View

Rockey D, Wang J, Lei L, Zhong G . Chlamydia vaccine candidates and tools for chlamydial antigen discovery. Expert Rev Vaccines. 2009; 8(10):1365-77. DOI: 10.1586/erv.09.98. View

Thomas N, Lusher M, Storey C, Clarke I . Plasmid diversity in Chlamydia. Microbiology (Reading). 1997; 143 ( Pt 6):1847-1854. DOI: 10.1099/00221287-143-6-1847. View

10.

Zhong G, Fan P, Ji H, Dong F, Huang Y . Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med. 2001; 193(8):935-42. PMC: 2193410. DOI: 10.1084/jem.193.8.935. View

11.

Huang Z, Feng Y, Chen D, Wu X, Huang S, Wang X . Structural basis for activation and inhibition of the secreted chlamydia protease CPAF. Cell Host Microbe. 2008; 4(6):529-42. DOI: 10.1016/j.chom.2008.10.005. View

12.

Caldwell H, Kromhout J, Schachter J . Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun. 1981; 31(3):1161-76. PMC: 351439. DOI: 10.1128/iai.31.3.1161-1176.1981. View

13.

Harding-Esch E, Edwards T, Sillah A, Sarr I, Roberts C, Snell P . Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?. PLoS Negl Trop Dis. 2009; 3(12):e573. PMC: 2791206. DOI: 10.1371/journal.pntd.0000573. View

14.

Sherman K, Daling J, Stergachis A, Weiss N, Foy H, Wang S . Sexually transmitted diseases and tubal pregnancy. Sex Transm Dis. 1990; 17(3):115-21. DOI: 10.1097/00007435-199007000-00001. View

15.

Zhong G . Killing me softly: chlamydial use of proteolysis for evading host defenses. Trends Microbiol. 2009; 17(10):467-74. PMC: 2755597. DOI: 10.1016/j.tim.2009.07.007. View

16.

Hybiske K, Stephens R . Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc Natl Acad Sci U S A. 2007; 104(27):11430-5. PMC: 2040915. DOI: 10.1073/pnas.0703218104. View

17.

Li D, Vaglenov A, Kim T, Wang C, Gao D, Kaltenboeck B . High-yield culture and purification of Chlamydiaceae bacteria. J Microbiol Methods. 2005; 61(1):17-24. DOI: 10.1016/j.mimet.2004.10.020. View

18.

Fan T, Lu H, Hu H, Shi L, McClarty G, Nance D . Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med. 1998; 187(4):487-96. PMC: 2212145. DOI: 10.1084/jem.187.4.487. View

19.

Li Z, Zhong Y, Lei L, Wu Y, Wang S, Zhong G . Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner. BMC Microbiol. 2008; 8:90. PMC: 2432062. DOI: 10.1186/1471-2180-8-90. View

20.

Dong F, Sharma J, Xiao Y, Zhong Y, Zhong G . Intramolecular dimerization is required for the chlamydia-secreted protease CPAF to degrade host transcriptional factors. Infect Immun. 2004; 72(7):3869-75. PMC: 427400. DOI: 10.1128/IAI.72.7.3869-3875.2004. View